Navigation Links
Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Date:2/12/2008

h and

development 3,754 (3,754) - - -

Other (income)/

expense, net (231) - 255 - 24

Special and acquisition

related charges 52 - (52) - -

Equity income (566) - - - (566)

(Loss)/income before

income taxes (3,340) 4,080 (203) 21 558

Income tax (benefit)/

expense (14) 89 2 1 78

Net (loss)/income

before cumulative

effect of a change

in accounting

principle $(3,326) $3,991 $(205) $20 $480

Cumulative effect

of a change in

accounting

principle, net

of tax - - - - -

Net (loss)/income $(3,326) $3,991 $(205) $20 $480

Preferred stock

dividends 38 - - - 38

Net (loss)/income

available to

common

shareholders $(3,364) $3,991 $(205) $20 $442

Diluted (loss)/

earnings per

common share:

(Loss)/earnings

available to

common

shareholders

before cumulative

effect of a change

in accounting

principle $ (2.08) $0.27

Cumulative effect

of a change in

accounting

principle, net

of tax - -

Diluted (loss)/

earnings per

common share $ (2.08) $0.27

Average common

shares outstanding

-diluted 1,621 1,648

SCHERING-PLOUGH CORPORATION

Re
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
2. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
3. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
4. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
5. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
6. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
9. Schering-Plough Completes Acquisition of Organon BioSciences
10. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
11. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2009)...ussex, U.K. and CLEVELAND, Nov. 18 ...usiness and premier provider of diagnostic systems..., has expanded its East Grinstead, U.K., manufactu... increasing global demand for its Sensititre®...n testing. The expanded facility has been fully va...
(Date:11/18/2009)...8 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NY...development company that identifies and advances a...ducts at various stages of development, announced ...ere presented today in a poster at the 2009 AACR-N... conference in Boston, Massachusetts. The reported...
(Date:11/18/2009)..., Nov. 18 Algenol Biofuels LLC, de...d the technology group The Linde Group have agre...n order to identify the optimum management of carb...que algae and photobioreactor technology. This coo...elop cost-efficient technologies that capture, sto...
(Date:11/18/2009)...nd HANGZHOU, China, Nov. 18 /PRNewswire-FirstCall/...ompany") (OTC Bulletin Board: NIUS), a leading U.S...selling nutritional products for children, today a...ducts will be distributed in Shanghai, the largest... year distribution contract with Hainan Qi Zheng P...
Breaking Biology Technology:TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 2TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 3TREK Diagnostic Systems Opens New U.K. Facility in East Grinstead to Meet Expanded Customer Demand for Microbiology Products 4YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 3Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 2Algenol Biofuels and The Linde Group Agree To Cooperate in CO2 and O2 Management For Biofuel Production From Algae 3Niusule Expands Geographic Footprint in China 2Niusule Expands Geographic Footprint in China 3
...yx, Inc.,(Nasdaq: SNMX ), a leading company focu...es to discover and develop novel flavor ingredient...ustries, announced today that Kent Snyder,the Comp... Vice President,Chief Financial and Business Offic..., January 7, 2009 at 9:00 a.m. Eastern Time (6:00 ...
...rmaceuticals,Inc. (Nasdaq: ISIS ) announces the ...ercise of its option to purchase Ibis Biosciences,...tion price will be, $215 million., ...a.m. ET / 5:30 a.m. PT, Where: http://www.i... Simply log onto our Web site listed, ...
...with Jatropha World Asia 2009, scheduled 16-17 Feb...s of interviews with top Jatropha decision makers ...stion and answer session was held with Pradip Bhar... D1-Williamson Magor Biofuel Limited. Offered by f...rtling insights into the direction of Jatropha as ...
Other Biology Technology:SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE 11TH ANNUAL NEEDHAM GROWTH STOCK CONFERENCE 2Webcast Alert: Isis Pharmaceuticals Announces That Abbott Exercised Its Option to Acquire Ibis Biosciences 2Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels 2Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels 3Jatropha World 2009 Advance Access: Surprisingly Candid Interview Series Examines Biofuel Predictions Compared to Fossil Fuels 4
(Date:11/22/2009)...tists at the Brain Research Centre, a partnership ...edicine and Vancouver Coastal Health Research Inst...chanism by which brain cells die following a strok...ge. The results of the study were recently publish...roke, many brain cells continue to die even after ...
(Date:11/20/2009)... highly precise measurements of plasma lipoprotein...onance spectroscopy (NMR), researchers led by Dani...vard Medical School in Boston, MA, the Framingham ...rtium in Stockholm, Sweden and Oxford, England per...le genome among 17,296 women of European ancestry ...
(Date:11/20/2009)... Grafton, Mass., November 19, 2009 The estimated ...try may be at risk of developing respiratory sympt...ing to a questionnaire study undertaken earlier th...mings School of Veterinary Medicine. , The study...orkersfound that 50 percent of individuals working...
Breaking Biology News(10 mins):New understanding about mechanism for cell death after stroke leads to possible therapy 2Genetic analysis helps dissect molecular basis of cardiovascular disease 2Barn personnel experience higher-than-average rates of respiratory symptoms 2Prognosis 3A A New Tool Now for Healthcare Reform and the Influenza Epidemic 3B 26amp 3B 238216 3BCell Membranes 26apos 3B Tell the Story 3B Prognost 55671 1Prognosis 3A A New Tool Now for Healthcare Reform and the Influenza Epidemic 3B 26amp 3B 238216 3BCell Membranes 26apos 3B Tell the Story 3B Prognost 55671 2Prognosis 3A A New Tool Now for Healthcare Reform and the Influenza Epidemic 3B 26amp 3B 238216 3BCell Membranes 26apos 3B Tell the Story 3B Prognost 55671 3Prognosis 3A A New Tool Now for Healthcare Reform and the Influenza Epidemic 3B 26amp 3B 238216 3BCell Membranes 26apos 3B Tell the Story 3B Prognost 55671 4Tarascon Publishing Presents Essential Translation Resource for Healthcare Providers with Non English Speaking Patients 55667 1Tarascon Publishing Presents Essential Translation Resource for Healthcare Providers with Non English Speaking Patients 55667 2Tarascon Publishing Presents Essential Translation Resource for Healthcare Providers with Non English Speaking Patients 55667 3Entomological Society of America names 2009 Fellows 9734 1
... (CVD) are major contributors to morbidity and mor...l, biochemical, and genetic risk factors can incre...s involved in the etiology of CVD are known, many ...des, scientists have searched for these genes with...with more targeted candidate gene studies. , Mast...
... to Pediatrics, edited and sponsored by the Nation...A), physicians will have access in one place to th...ogical, behavioral, and environmental changes duri...ation, maintenance, and acceleration of illegal us...ime collection of where science is in our understa...
...g to develop a clearer picture of what makes some ...team of researchers who last year identified the f...as now identified a further twenty regions of the ... of up to 6cm. , The results, published together...journal Nature Genetics, mean that scientists now ...
Other Biology News:Genetic variants of USF1 are associated with the increased risk for cardiovascular disease 2Pediatricians alerted to the developmental nature of underage drinking in special journal supplement 2Pediatricians alerted to the developmental nature of underage drinking in special journal supplement 3Pediatricians alerted to the developmental nature of underage drinking in special journal supplement 4A tall story: New research adds to growing body of knowledge of genetics of height 2
Mouse Anti-Rad17 Monoclonal Antibody, Unconjugated, Clone 1C6/2 from Abcam
MMP-2/MMP-9 Inhibitor IV [SB-3CT] from CHEMICON
Mouse Anti-Mucin 3 (MUC3) Ab-2 Monoclonal Antibody, Unconjugated, Clone 1143/B7 from Lab Vision
Costar 6 Well Cell Culture Plate, 9.5 cm2, 34.8 mm Diam. Well, Sterile from Sigma-Aldrich
Biology Products: